[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Antibiotics and Antimycotics Market Insights, Forecast to 2029

November 2023 | 106 pages | ID: GE0C6ACF5D81EN
QYResearch

US$ 4,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report presents an overview of global market for Antibiotics and Antimycotics, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Antibiotics and Antimycotics, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Antibiotics and Antimycotics, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Antibiotics and Antimycotics sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global Antibiotics and Antimycotics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for Antibiotics and Antimycotics sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Pfizer, Novartis, Sanofi, Roche, Merck, GSK, Johnson & Johnson, AstraZeneca and Eli Lilly, etc.

By Company
  • Pfizer
  • Novartis
  • Sanofi
  • Roche
  • Merck
  • GSK
  • Johnson & Johnson
  • AstraZeneca
  • Eli Lilly
  • AbbVie
  • Bayer
Segment by Type
  • Penicillins
  • Cephalosporins
  • Carbapenems
  • Macrolides
  • Aminoglycosides
  • Quinolones (Fluoroquinolones)
  • Sulfonamides
  • Tetracyclines
  • Other
Segment by Application
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Segment by Region
  • US & Canada
    • U.S.
    • Canada
  • China
  • Asia (excluding China)
    • Japan
    • South Korea
    • China Taiwan
  • Southeast Asia
    • India
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Middle East, Africa, Latin America
    • Brazil
    • Mexico
    • Turkey
    • Israel
    • GCC Countries
Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales (consumption), revenue of Antibiotics and Antimycotics in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 3: Detailed analysis of Antibiotics and Antimycotics manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.

Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.

Chapter 8: China by type, by application sales and revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.

Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antibiotics and Antimycotics sales, revenue, price, gross margin, and recent development, etc.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: The main points and conclusions of the report.
1 STUDY COVERAGE

1.1 Antibiotics and Antimycotics Product Introduction
1.2 Market by Type
  1.2.1 Global Antibiotics and Antimycotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
  1.2.2 Penicillins
  1.2.3 Cephalosporins
  1.2.4 Carbapenems
  1.2.5 Macrolides
  1.2.6 Aminoglycosides
  1.2.7 Quinolones (Fluoroquinolones)
  1.2.8 Sulfonamides
  1.2.9 Tetracyclines
  1.2.10 Other
1.3 Market by Application
  1.3.1 Global Antibiotics and Antimycotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
  1.3.2 Hospital Pharmacy
  1.3.3 Retail Pharmacy
  1.3.4 Online Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 EXECUTIVE SUMMARY

2.1 Global Antibiotics and Antimycotics Sales Estimates and Forecasts 2018-2029
2.2 Global Antibiotics and Antimycotics Revenue by Region
  2.2.1 Global Antibiotics and Antimycotics Revenue by Region: 2018 VS 2022 VS 2029
  2.2.2 Global Antibiotics and Antimycotics Revenue by Region (2018-2023)
  2.2.3 Global Antibiotics and Antimycotics Revenue by Region (2024-2029)
  2.2.4 Global Antibiotics and Antimycotics Revenue Market Share by Region (2018-2029)
2.3 Global Antibiotics and Antimycotics Sales Estimates and Forecasts 2018-2029
2.4 Global Antibiotics and Antimycotics Sales by Region
  2.4.1 Global Antibiotics and Antimycotics Sales by Region: 2018 VS 2022 VS 2029
  2.4.2 Global Antibiotics and Antimycotics Sales by Region (2018-2023)
  2.4.3 Global Antibiotics and Antimycotics Sales by Region (2024-2029)
  2.4.4 Global Antibiotics and Antimycotics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 COMPETITION BY MANUFACTURES

3.1 Global Antibiotics and Antimycotics Sales by Manufacturers
  3.1.1 Global Antibiotics and Antimycotics Sales by Manufacturers (2018-2023)
  3.1.2 Global Antibiotics and Antimycotics Sales Market Share by Manufacturers (2018-2023)
  3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antibiotics and Antimycotics in 2022
3.2 Global Antibiotics and Antimycotics Revenue by Manufacturers
  3.2.1 Global Antibiotics and Antimycotics Revenue by Manufacturers (2018-2023)
  3.2.2 Global Antibiotics and Antimycotics Revenue Market Share by Manufacturers (2018-2023)
  3.2.3 Global Top 10 and Top 5 Companies by Antibiotics and Antimycotics Revenue in 2022
3.3 Global Key Players of Antibiotics and Antimycotics, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Antibiotics and Antimycotics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
  3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  3.5.2 Global Antibiotics and Antimycotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Antibiotics and Antimycotics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Antibiotics and Antimycotics, Product Offered and Application
3.8 Global Key Manufacturers of Antibiotics and Antimycotics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 MARKET SIZE BY TYPE

4.1 Global Antibiotics and Antimycotics Sales by Type
  4.1.1 Global Antibiotics and Antimycotics Historical Sales by Type (2018-2023)
  4.1.2 Global Antibiotics and Antimycotics Forecasted Sales by Type (2024-2029)
  4.1.3 Global Antibiotics and Antimycotics Sales Market Share by Type (2018-2029)
4.2 Global Antibiotics and Antimycotics Revenue by Type
  4.2.1 Global Antibiotics and Antimycotics Historical Revenue by Type (2018-2023)
  4.2.2 Global Antibiotics and Antimycotics Forecasted Revenue by Type (2024-2029)
  4.2.3 Global Antibiotics and Antimycotics Revenue Market Share by Type (2018-2029)
4.3 Global Antibiotics and Antimycotics Price by Type
  4.3.1 Global Antibiotics and Antimycotics Price by Type (2018-2023)
  4.3.2 Global Antibiotics and Antimycotics Price Forecast by Type (2024-2029)

5 MARKET SIZE BY APPLICATION

5.1 Global Antibiotics and Antimycotics Sales by Application
  5.1.1 Global Antibiotics and Antimycotics Historical Sales by Application (2018-2023)
  5.1.2 Global Antibiotics and Antimycotics Forecasted Sales by Application (2024-2029)
  5.1.3 Global Antibiotics and Antimycotics Sales Market Share by Application (2018-2029)
5.2 Global Antibiotics and Antimycotics Revenue by Application
  5.2.1 Global Antibiotics and Antimycotics Historical Revenue by Application (2018-2023)
  5.2.2 Global Antibiotics and Antimycotics Forecasted Revenue by Application (2024-2029)
  5.2.3 Global Antibiotics and Antimycotics Revenue Market Share by Application (2018-2029)
5.3 Global Antibiotics and Antimycotics Price by Application
  5.3.1 Global Antibiotics and Antimycotics Price by Application (2018-2023)
  5.3.2 Global Antibiotics and Antimycotics Price Forecast by Application (2024-2029)

6 US & CANADA

6.1 US & Canada Antibiotics and Antimycotics Market Size by Type
  6.1.1 US & Canada Antibiotics and Antimycotics Sales by Type (2018-2029)
  6.1.2 US & Canada Antibiotics and Antimycotics Revenue by Type (2018-2029)
6.2 US & Canada Antibiotics and Antimycotics Market Size by Application
  6.2.1 US & Canada Antibiotics and Antimycotics Sales by Application (2018-2029)
  6.2.2 US & Canada Antibiotics and Antimycotics Revenue by Application (2018-2029)
6.3 US & Canada Antibiotics and Antimycotics Market Size by Country
  6.3.1 US & Canada Antibiotics and Antimycotics Revenue by Country: 2018 VS 2022 VS 2029
  6.3.2 US & Canada Antibiotics and Antimycotics Sales by Country (2018-2029)
  6.3.3 US & Canada Antibiotics and Antimycotics Revenue by Country (2018-2029)
  6.3.4 US
  6.3.5 Canada

7 EUROPE

7.1 Europe Antibiotics and Antimycotics Market Size by Type
  7.1.1 Europe Antibiotics and Antimycotics Sales by Type (2018-2029)
  7.1.2 Europe Antibiotics and Antimycotics Revenue by Type (2018-2029)
7.2 Europe Antibiotics and Antimycotics Market Size by Application
  7.2.1 Europe Antibiotics and Antimycotics Sales by Application (2018-2029)
  7.2.2 Europe Antibiotics and Antimycotics Revenue by Application (2018-2029)
7.3 Europe Antibiotics and Antimycotics Market Size by Country
  7.3.1 Europe Antibiotics and Antimycotics Revenue by Country: 2018 VS 2022 VS 2029
  7.3.2 Europe Antibiotics and Antimycotics Sales by Country (2018-2029)
  7.3.3 Europe Antibiotics and Antimycotics Revenue by Country (2018-2029)
  7.3.4 Germany
  7.3.5 France
  7.3.6 U.K.
  7.3.7 Italy
  7.3.8 Russia

8 CHINA

8.1 China Antibiotics and Antimycotics Market Size
  8.1.1 China Antibiotics and Antimycotics Sales (2018-2029)
  8.1.2 China Antibiotics and Antimycotics Revenue (2018-2029)
8.2 China Antibiotics and Antimycotics Market Size by Application
  8.2.1 China Antibiotics and Antimycotics Sales by Application (2018-2029)
  8.2.2 China Antibiotics and Antimycotics Revenue by Application (2018-2029)

9 ASIA (EXCLUDING CHINA)

9.1 Asia Antibiotics and Antimycotics Market Size by Type
  9.1.1 Asia Antibiotics and Antimycotics Sales by Type (2018-2029)
  9.1.2 Asia Antibiotics and Antimycotics Revenue by Type (2018-2029)
9.2 Asia Antibiotics and Antimycotics Market Size by Application
  9.2.1 Asia Antibiotics and Antimycotics Sales by Application (2018-2029)
  9.2.2 Asia Antibiotics and Antimycotics Revenue by Application (2018-2029)
9.3 Asia Antibiotics and Antimycotics Sales by Region
  9.3.1 Asia Antibiotics and Antimycotics Revenue by Region: 2018 VS 2022 VS 2029
  9.3.2 Asia Antibiotics and Antimycotics Revenue by Region (2018-2029)
  9.3.3 Asia Antibiotics and Antimycotics Sales by Region (2018-2029)
  9.3.4 Japan
  9.3.5 South Korea
  9.3.6 China Taiwan
  9.3.7 Southeast Asia
  9.3.8 India

10 MIDDLE EAST, AFRICA AND LATIN AMERICA

10.1 Middle East, Africa and Latin America Antibiotics and Antimycotics Market Size by Type
  10.1.1 Middle East, Africa and Latin America Antibiotics and Antimycotics Sales by Type (2018-2029)
  10.1.2 Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Antibiotics and Antimycotics Market Size by Application
  10.2.1 Middle East, Africa and Latin America Antibiotics and Antimycotics Sales by Application (2018-2029)
  10.2.2 Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Antibiotics and Antimycotics Sales by Country
  10.3.1 Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue by Country: 2018 VS 2022 VS 2029
  10.3.2 Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue by Country (2018-2029)
  10.3.3 Middle East, Africa and Latin America Antibiotics and Antimycotics Sales by Country (2018-2029)
  10.3.4 Brazil
  10.3.5 Mexico
  10.3.6 Turkey
  10.3.7 Israel
  10.3.8 GCC Countries

11 COMPANY PROFILES

11.1 Pfizer
  11.1.1 Pfizer Company Information
  11.1.2 Pfizer Overview
  11.1.3 Pfizer Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.1.4 Pfizer Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.1.5 Pfizer Recent Developments
11.2 Novartis
  11.2.1 Novartis Company Information
  11.2.2 Novartis Overview
  11.2.3 Novartis Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.2.4 Novartis Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.2.5 Novartis Recent Developments
11.3 Sanofi
  11.3.1 Sanofi Company Information
  11.3.2 Sanofi Overview
  11.3.3 Sanofi Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.3.4 Sanofi Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.3.5 Sanofi Recent Developments
11.4 Roche
  11.4.1 Roche Company Information
  11.4.2 Roche Overview
  11.4.3 Roche Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.4.4 Roche Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.4.5 Roche Recent Developments
11.5 Merck
  11.5.1 Merck Company Information
  11.5.2 Merck Overview
  11.5.3 Merck Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.5.4 Merck Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.5.5 Merck Recent Developments
11.6 GSK
  11.6.1 GSK Company Information
  11.6.2 GSK Overview
  11.6.3 GSK Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.6.4 GSK Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.6.5 GSK Recent Developments
11.7 Johnson & Johnson
  11.7.1 Johnson & Johnson Company Information
  11.7.2 Johnson & Johnson Overview
  11.7.3 Johnson & Johnson Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.7.4 Johnson & Johnson Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.7.5 Johnson & Johnson Recent Developments
11.8 AstraZeneca
  11.8.1 AstraZeneca Company Information
  11.8.2 AstraZeneca Overview
  11.8.3 AstraZeneca Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.8.4 AstraZeneca Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.8.5 AstraZeneca Recent Developments
11.9 Eli Lilly
  11.9.1 Eli Lilly Company Information
  11.9.2 Eli Lilly Overview
  11.9.3 Eli Lilly Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.9.4 Eli Lilly Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.9.5 Eli Lilly Recent Developments
11.10 AbbVie
  11.10.1 AbbVie Company Information
  11.10.2 AbbVie Overview
  11.10.3 AbbVie Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.10.4 AbbVie Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.10.5 AbbVie Recent Developments
11.11 Bayer
  11.11.1 Bayer Company Information
  11.11.2 Bayer Overview
  11.11.3 Bayer Antibiotics and Antimycotics Sales, Price, Revenue and Gross Margin (2018-2023)
  11.11.4 Bayer Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
  11.11.5 Bayer Recent Developments

12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS

12.1 Antibiotics and Antimycotics Industry Chain Analysis
12.2 Antibiotics and Antimycotics Key Raw Materials
  12.2.1 Key Raw Materials
  12.2.2 Raw Materials Key Suppliers
12.3 Antibiotics and Antimycotics Production Mode & Process
12.4 Antibiotics and Antimycotics Sales and Marketing
  12.4.1 Antibiotics and Antimycotics Sales Channels
  12.4.2 Antibiotics and Antimycotics Distributors
12.5 Antibiotics and Antimycotics Customers

13 MARKET DYNAMICS

13.1 Antibiotics and Antimycotics Industry Trends
13.2 Antibiotics and Antimycotics Market Drivers
13.3 Antibiotics and Antimycotics Market Challenges
13.4 Antibiotics and Antimycotics Market Restraints

14 KEY FINDINGS IN THE GLOBAL ANTIBIOTICS AND ANTIMYCOTICS STUDY


15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES

Table 1. Global Antibiotics and Antimycotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Penicillins
Table 3. Major Manufacturers of Cephalosporins
Table 4. Major Manufacturers of Carbapenems
Table 5. Major Manufacturers of Macrolides
Table 6. Major Manufacturers of Aminoglycosides
Table 7. Major Manufacturers of Quinolones (Fluoroquinolones)
Table 8. Major Manufacturers of Sulfonamides
Table 9. Major Manufacturers of Tetracyclines
Table 10. Major Manufacturers of Other
Table 11. Global Antibiotics and Antimycotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Antibiotics and Antimycotics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Antibiotics and Antimycotics Revenue by Region (2018-2023) & (US$ Million)
Table 14. Global Antibiotics and Antimycotics Revenue by Region (2024-2029) & (US$ Million)
Table 15. Global Antibiotics and Antimycotics Revenue Market Share by Region (2018-2023)
Table 16. Global Antibiotics and Antimycotics Revenue Market Share by Region (2024-2029)
Table 17. Global Antibiotics and Antimycotics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 18. Global Antibiotics and Antimycotics Sales by Region (2018-2023) & (K MT)
Table 19. Global Antibiotics and Antimycotics Sales by Region (2024-2029) & (K MT)
Table 20. Global Antibiotics and Antimycotics Sales Market Share by Region (2018-2023)
Table 21. Global Antibiotics and Antimycotics Sales Market Share by Region (2024-2029)
Table 22. Global Antibiotics and Antimycotics Sales by Manufacturers (2018-2023) & (K MT)
Table 23. Global Antibiotics and Antimycotics Sales Share by Manufacturers (2018-2023)
Table 24. Global Antibiotics and Antimycotics Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 25. Global Antibiotics and Antimycotics Revenue Share by Manufacturers (2018-2023)
Table 26. Global Key Players of Antibiotics and Antimycotics, Industry Ranking, 2021 VS 2022 VS 2023
Table 27. Antibiotics and Antimycotics Price by Manufacturers 2018-2023 (USD/MT)
Table 28. Global Antibiotics and Antimycotics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 29. Global Antibiotics and Antimycotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antibiotics and Antimycotics as of 2022)
Table 30. Global Key Manufacturers of Antibiotics and Antimycotics, Manufacturing Base Distribution and Headquarters
Table 31. Global Key Manufacturers of Antibiotics and Antimycotics, Product Offered and Application
Table 32. Global Key Manufacturers of Antibiotics and Antimycotics, Date of Enter into This Industry
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Antibiotics and Antimycotics Sales by Type (2018-2023) & (K MT)
Table 35. Global Antibiotics and Antimycotics Sales by Type (2024-2029) & (K MT)
Table 36. Global Antibiotics and Antimycotics Sales Share by Type (2018-2023)
Table 37. Global Antibiotics and Antimycotics Sales Share by Type (2024-2029)
Table 38. Global Antibiotics and Antimycotics Revenue by Type (2018-2023) & (US$ Million)
Table 39. Global Antibiotics and Antimycotics Revenue by Type (2024-2029) & (US$ Million)
Table 40. Global Antibiotics and Antimycotics Revenue Share by Type (2018-2023)
Table 41. Global Antibiotics and Antimycotics Revenue Share by Type (2024-2029)
Table 42. Antibiotics and Antimycotics Price by Type (2018-2023) & (USD/MT)
Table 43. Global Antibiotics and Antimycotics Price Forecast by Type (2024-2029) & (USD/MT)
Table 44. Global Antibiotics and Antimycotics Sales by Application (2018-2023) & (K MT)
Table 45. Global Antibiotics and Antimycotics Sales by Application (2024-2029) & (K MT)
Table 46. Global Antibiotics and Antimycotics Sales Share by Application (2018-2023)
Table 47. Global Antibiotics and Antimycotics Sales Share by Application (2024-2029)
Table 48. Global Antibiotics and Antimycotics Revenue by Application (2018-2023) & (US$ Million)
Table 49. Global Antibiotics and Antimycotics Revenue by Application (2024-2029) & (US$ Million)
Table 50. Global Antibiotics and Antimycotics Revenue Share by Application (2018-2023)
Table 51. Global Antibiotics and Antimycotics Revenue Share by Application (2024-2029)
Table 52. Antibiotics and Antimycotics Price by Application (2018-2023) & (USD/MT)
Table 53. Global Antibiotics and Antimycotics Price Forecast by Application (2024-2029) & (USD/MT)
Table 54. US & Canada Antibiotics and Antimycotics Sales by Type (2018-2023) & (K MT)
Table 55. US & Canada Antibiotics and Antimycotics Sales by Type (2024-2029) & (K MT)
Table 56. US & Canada Antibiotics and Antimycotics Revenue by Type (2018-2023) & (US$ Million)
Table 57. US & Canada Antibiotics and Antimycotics Revenue by Type (2024-2029) & (US$ Million)
Table 58. US & Canada Antibiotics and Antimycotics Sales by Application (2018-2023) & (K MT)
Table 59. US & Canada Antibiotics and Antimycotics Sales by Application (2024-2029) & (K MT)
Table 60. US & Canada Antibiotics and Antimycotics Revenue by Application (2018-2023) & (US$ Million)
Table 61. US & Canada Antibiotics and Antimycotics Revenue by Application (2024-2029) & (US$ Million)
Table 62. US & Canada Antibiotics and Antimycotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 63. US & Canada Antibiotics and Antimycotics Revenue by Country (2018-2023) & (US$ Million)
Table 64. US & Canada Antibiotics and Antimycotics Revenue by Country (2024-2029) & (US$ Million)
Table 65. US & Canada Antibiotics and Antimycotics Sales by Country (2018-2023) & (K MT)
Table 66. US & Canada Antibiotics and Antimycotics Sales by Country (2024-2029) & (K MT)
Table 67. Europe Antibiotics and Antimycotics Sales by Type (2018-2023) & (K MT)
Table 68. Europe Antibiotics and Antimycotics Sales by Type (2024-2029) & (K MT)
Table 69. Europe Antibiotics and Antimycotics Revenue by Type (2018-2023) & (US$ Million)
Table 70. Europe Antibiotics and Antimycotics Revenue by Type (2024-2029) & (US$ Million)
Table 71. Europe Antibiotics and Antimycotics Sales by Application (2018-2023) & (K MT)
Table 72. Europe Antibiotics and Antimycotics Sales by Application (2024-2029) & (K MT)
Table 73. Europe Antibiotics and Antimycotics Revenue by Application (2018-2023) & (US$ Million)
Table 74. Europe Antibiotics and Antimycotics Revenue by Application (2024-2029) & (US$ Million)
Table 75. Europe Antibiotics and Antimycotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 76. Europe Antibiotics and Antimycotics Revenue by Country (2018-2023) & (US$ Million)
Table 77. Europe Antibiotics and Antimycotics Revenue by Country (2024-2029) & (US$ Million)
Table 78. Europe Antibiotics and Antimycotics Sales by Country (2018-2023) & (K MT)
Table 79. Europe Antibiotics and Antimycotics Sales by Country (2024-2029) & (K MT)
Table 80. China Antibiotics and Antimycotics Sales by Type (2018-2023) & (K MT)
Table 81. China Antibiotics and Antimycotics Sales by Type (2024-2029) & (K MT)
Table 82. China Antibiotics and Antimycotics Revenue by Type (2018-2023) & (US$ Million)
Table 83. China Antibiotics and Antimycotics Revenue by Type (2024-2029) & (US$ Million)
Table 84. China Antibiotics and Antimycotics Sales by Application (2018-2023) & (K MT)
Table 85. China Antibiotics and Antimycotics Sales by Application (2024-2029) & (K MT)
Table 86. China Antibiotics and Antimycotics Revenue by Application (2018-2023) & (US$ Million)
Table 87. China Antibiotics and Antimycotics Revenue by Application (2024-2029) & (US$ Million)
Table 88. Asia Antibiotics and Antimycotics Sales by Type (2018-2023) & (K MT)
Table 89. Asia Antibiotics and Antimycotics Sales by Type (2024-2029) & (K MT)
Table 90. Asia Antibiotics and Antimycotics Revenue by Type (2018-2023) & (US$ Million)
Table 91. Asia Antibiotics and Antimycotics Revenue by Type (2024-2029) & (US$ Million)
Table 92. Asia Antibiotics and Antimycotics Sales by Application (2018-2023) & (K MT)
Table 93. Asia Antibiotics and Antimycotics Sales by Application (2024-2029) & (K MT)
Table 94. Asia Antibiotics and Antimycotics Revenue by Application (2018-2023) & (US$ Million)
Table 95. Asia Antibiotics and Antimycotics Revenue by Application (2024-2029) & (US$ Million)
Table 96. Asia Antibiotics and Antimycotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 97. Asia Antibiotics and Antimycotics Revenue by Region (2018-2023) & (US$ Million)
Table 98. Asia Antibiotics and Antimycotics Revenue by Region (2024-2029) & (US$ Million)
Table 99. Asia Antibiotics and Antimycotics Sales by Region (2018-2023) & (K MT)
Table 100. Asia Antibiotics and Antimycotics Sales by Region (2024-2029) & (K MT)
Table 101. Middle East, Africa and Latin America Antibiotics and Antimycotics Sales by Type (2018-2023) & (K MT)
Table 102. Middle East, Africa and Latin America Antibiotics and Antimycotics Sales by Type (2024-2029) & (K MT)
Table 103. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue by Type (2018-2023) & (US$ Million)
Table 104. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue by Type (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Antibiotics and Antimycotics Sales by Application (2018-2023) & (K MT)
Table 106. Middle East, Africa and Latin America Antibiotics and Antimycotics Sales by Application (2024-2029) & (K MT)
Table 107. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue by Application (2018-2023) & (US$ Million)
Table 108. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue by Application (2024-2029) & (US$ Million)
Table 109. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 110. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue by Country (2018-2023) & (US$ Million)
Table 111. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue by Country (2024-2029) & (US$ Million)
Table 112. Middle East, Africa and Latin America Antibiotics and Antimycotics Sales by Country (2018-2023) & (K MT)
Table 113. Middle East, Africa and Latin America Antibiotics and Antimycotics Sales by Country (2024-2029) & (K MT)
Table 114. Pfizer Company Information
Table 115. Pfizer Description and Major Businesses
Table 116. Pfizer Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Pfizer Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Pfizer Recent Developments
Table 119. Novartis Company Information
Table 120. Novartis Description and Major Businesses
Table 121. Novartis Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Novartis Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Novartis Recent Developments
Table 124. Sanofi Company Information
Table 125. Sanofi Description and Major Businesses
Table 126. Sanofi Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Sanofi Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Sanofi Recent Developments
Table 129. Roche Company Information
Table 130. Roche Description and Major Businesses
Table 131. Roche Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. Roche Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Roche Recent Developments
Table 134. Merck Company Information
Table 135. Merck Description and Major Businesses
Table 136. Merck Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 137. Merck Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Merck Recent Developments
Table 139. GSK Company Information
Table 140. GSK Description and Major Businesses
Table 141. GSK Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 142. GSK Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. GSK Recent Developments
Table 144. Johnson & Johnson Company Information
Table 145. Johnson & Johnson Description and Major Businesses
Table 146. Johnson & Johnson Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 147. Johnson & Johnson Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Johnson & Johnson Recent Developments
Table 149. AstraZeneca Company Information
Table 150. AstraZeneca Description and Major Businesses
Table 151. AstraZeneca Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 152. AstraZeneca Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. AstraZeneca Recent Developments
Table 154. Eli Lilly Company Information
Table 155. Eli Lilly Description and Major Businesses
Table 156. Eli Lilly Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 157. Eli Lilly Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. Eli Lilly Recent Developments
Table 159. AbbVie Company Information
Table 160. AbbVie Description and Major Businesses
Table 161. AbbVie Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 162. AbbVie Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. AbbVie Recent Developments
Table 164. Bayer Company Information
Table 165. Bayer Description and Major Businesses
Table 166. Bayer Antibiotics and Antimycotics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 167. Bayer Antibiotics and Antimycotics Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. Bayer Recent Developments
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Antibiotics and Antimycotics Distributors List
Table 172. Antibiotics and Antimycotics Customers List
Table 173. Antibiotics and Antimycotics Market Trends
Table 174. Antibiotics and Antimycotics Market Drivers
Table 175. Antibiotics and Antimycotics Market Challenges
Table 176. Antibiotics and Antimycotics Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Antibiotics and Antimycotics Product Picture
Figure 2. Global Antibiotics and Antimycotics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Antibiotics and Antimycotics Market Share by Type in 2022 & 2029
Figure 4. Penicillins Product Picture
Figure 5. Cephalosporins Product Picture
Figure 6. Carbapenems Product Picture
Figure 7. Macrolides Product Picture
Figure 8. Aminoglycosides Product Picture
Figure 9. Quinolones (Fluoroquinolones) Product Picture
Figure 10. Sulfonamides Product Picture
Figure 11. Tetracyclines Product Picture
Figure 12. Other Product Picture
Figure 13. Global Antibiotics and Antimycotics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 14. Global Antibiotics and Antimycotics Market Share by Application in 2022 & 2029
Figure 15. Hospital Pharmacy
Figure 16. Retail Pharmacy
Figure 17. Online Pharmacy
Figure 18. Antibiotics and Antimycotics Report Years Considered
Figure 19. Global Antibiotics and Antimycotics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 20. Global Antibiotics and Antimycotics Revenue 2018-2029 (US$ Million)
Figure 21. Global Antibiotics and Antimycotics Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 22. Global Antibiotics and Antimycotics Revenue Market Share by Region (2018-2029)
Figure 23. Global Antibiotics and Antimycotics Sales 2018-2029 ((K MT)
Figure 24. Global Antibiotics and Antimycotics Sales Market Share by Region (2018-2029)
Figure 25. US & Canada Antibiotics and Antimycotics Sales YoY (2018-2029) & (K MT)
Figure 26. US & Canada Antibiotics and Antimycotics Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Europe Antibiotics and Antimycotics Sales YoY (2018-2029) & (K MT)
Figure 28. Europe Antibiotics and Antimycotics Revenue YoY (2018-2029) & (US$ Million)
Figure 29. China Antibiotics and Antimycotics Sales YoY (2018-2029) & (K MT)
Figure 30. China Antibiotics and Antimycotics Revenue YoY (2018-2029) & (US$ Million)
Figure 31. Asia (excluding China) Antibiotics and Antimycotics Sales YoY (2018-2029) & (K MT)
Figure 32. Asia (excluding China) Antibiotics and Antimycotics Revenue YoY (2018-2029) & (US$ Million)
Figure 33. Middle East, Africa and Latin America Antibiotics and Antimycotics Sales YoY (2018-2029) & (K MT)
Figure 34. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue YoY (2018-2029) & (US$ Million)
Figure 35. The Antibiotics and Antimycotics Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 36. The Top 5 and 10 Largest Manufacturers of Antibiotics and Antimycotics in the World: Market Share by Antibiotics and Antimycotics Revenue in 2022
Figure 37. Global Antibiotics and Antimycotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 38. Global Antibiotics and Antimycotics Sales Market Share by Type (2018-2029)
Figure 39. Global Antibiotics and Antimycotics Revenue Market Share by Type (2018-2029)
Figure 40. Global Antibiotics and Antimycotics Sales Market Share by Application (2018-2029)
Figure 41. Global Antibiotics and Antimycotics Revenue Market Share by Application (2018-2029)
Figure 42. US & Canada Antibiotics and Antimycotics Sales Market Share by Type (2018-2029)
Figure 43. US & Canada Antibiotics and Antimycotics Revenue Market Share by Type (2018-2029)
Figure 44. US & Canada Antibiotics and Antimycotics Sales Market Share by Application (2018-2029)
Figure 45. US & Canada Antibiotics and Antimycotics Revenue Market Share by Application (2018-2029)
Figure 46. US & Canada Antibiotics and Antimycotics Revenue Share by Country (2018-2029)
Figure 47. US & Canada Antibiotics and Antimycotics Sales Share by Country (2018-2029)
Figure 48. U.S. Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 49. Canada Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 50. Europe Antibiotics and Antimycotics Sales Market Share by Type (2018-2029)
Figure 51. Europe Antibiotics and Antimycotics Revenue Market Share by Type (2018-2029)
Figure 52. Europe Antibiotics and Antimycotics Sales Market Share by Application (2018-2029)
Figure 53. Europe Antibiotics and Antimycotics Revenue Market Share by Application (2018-2029)
Figure 54. Europe Antibiotics and Antimycotics Revenue Share by Country (2018-2029)
Figure 55. Europe Antibiotics and Antimycotics Sales Share by Country (2018-2029)
Figure 56. Germany Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 57. France Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 58. U.K. Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 59. Italy Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 60. Russia Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 61. China Antibiotics and Antimycotics Sales Market Share by Type (2018-2029)
Figure 62. China Antibiotics and Antimycotics Revenue Market Share by Type (2018-2029)
Figure 63. China Antibiotics and Antimycotics Sales Market Share by Application (2018-2029)
Figure 64. China Antibiotics and Antimycotics Revenue Market Share by Application (2018-2029)
Figure 65. Asia Antibiotics and Antimycotics Sales Market Share by Type (2018-2029)
Figure 66. Asia Antibiotics and Antimycotics Revenue Market Share by Type (2018-2029)
Figure 67. Asia Antibiotics and Antimycotics Sales Market Share by Application (2018-2029)
Figure 68. Asia Antibiotics and Antimycotics Revenue Market Share by Application (2018-2029)
Figure 69. Asia Antibiotics and Antimycotics Revenue Share by Region (2018-2029)
Figure 70. Asia Antibiotics and Antimycotics Sales Share by Region (2018-2029)
Figure 71. Japan Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 72. South Korea Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 73. China Taiwan Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 74. Southeast Asia Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 75. India Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 76. Middle East, Africa and Latin America Antibiotics and Antimycotics Sales Market Share by Type (2018-2029)
Figure 77. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue Market Share by Type (2018-2029)
Figure 78. Middle East, Africa and Latin America Antibiotics and Antimycotics Sales Market Share by Application (2018-2029)
Figure 79. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue Market Share by Application (2018-2029)
Figure 80. Middle East, Africa and Latin America Antibiotics and Antimycotics Revenue Share by Country (2018-2029)
Figure 81. Middle East, Africa and Latin America Antibiotics and Antimycotics Sales Share by Country (2018-2029)
Figure 82. Brazil Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 83. Mexico Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 84. Turkey Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 85. Israel Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 86. GCC Countries Antibiotics and Antimycotics Revenue (2018-2029) & (US$ Million)
Figure 87. Antibiotics and Antimycotics Value Chain
Figure 88. Antibiotics and Antimycotics Production Process
Figure 89. Channels of Distribution
Figure 90. Distributors Profiles
Figure 91. Bottom-up and Top-down Approaches for This Report
Figure 92. Data Triangulation
Figure 93. Key Executives Interviewed


More Publications